Bronchogen — Khavinson bioregulator — bronchial
Bronchogen (AEDG) targets bronchial epithelial tissue. Very similar to Chonluten structurally. Designed for bronchial epithelium regeneration and anti-inflammatory support. Limited human data; primarily used in Russian bioregulator protocols for respiratory indications.
Overview
This page is part of Hormonaly's evidence-graded compound library. All clinical claims are linked to peer-reviewed sources via our dual-layer citation verification pipeline.
Compound Class
Khavinson bioregulator — bronchial
Mechanism of Action
Bronchogen (AEDG) targets bronchial epithelial tissue. Very similar to Chonluten structurally. Designed for bronchial epithelium regeneration and anti-inflammatory support. Limited human data; primarily used in Russian bioregulator protocols for respiratory indications.
Regulatory Status
Not FDA approved. Research peptide.
Evidence Level
Very Low — limited published data; evidence from Khavinson group only.